Inogen (INGN) Shares Outstanding (Diluted Average) (2012 - 2026)
Inogen (INGN) reported Shares Outstanding (Diluted Average) of $27.3 million for Q1 2026, up 8.58% year-over-year from $25.2 million in Q1 2025, and up 2.71% quarter-over-quarter from $26.6 million in Q4 2025.
Inogen (INGN) Shares Outstanding (Diluted Average) (2012 - 2026) Analysis & Trends
Inogen (INGN) has 12 years of Shares Outstanding (Diluted Average) data on file, last reported at $27.3 million in Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $27.3 million, up 8.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.3 million (up 8.58% YoY), and the FY2025 annual result was $26.6 million, up 12.46% from the prior year.
- Shares Outstanding (Diluted Average) climbed to $27.3 million in Q1 2026 per INGN's latest filing, from $26.6 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $27.3 million in Q1 2026 and troughed at $22.8 million in Q1 2022.
- A 5-year average of $24.1 million and a median of $23.4 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Diluted Average) slipped 0.13% in 2022, then grew 14.69% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $22.9 million in 2022, then rose by 1.42% to $23.2 million in 2023, then increased by 2.06% to $23.7 million in 2024, then gained by 12.46% to $26.6 million in 2025, then increased by 2.71% to $27.3 million in 2026.
- Business Quant data shows INGN's Shares Outstanding (Diluted Average) at $27.3 million in Q1 2026, $26.6 million in Q4 2025, and $26.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | 27.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.32 Mn |
| Dec 31, 2025 | 26.60 Mn |
| Sep 30, 2025 | 26.41 Mn |
| Jun 30, 2025 | 26.96 Mn |
| Mar 31, 2025 | 25.16 Mn |
| Dec 31, 2024 | 23.65 Mn |
| Sep 30, 2024 | 23.75 Mn |
| Jun 30, 2024 | 23.51 Mn |
| Mar 31, 2024 | 23.40 Mn |
| Dec 31, 2023 | 23.18 Mn |
| Sep 30, 2023 | 23.13 Mn |
| Jun 30, 2023 | 23.08 Mn |
| Mar 31, 2023 | 23.01 Mn |
| Dec 31, 2022 | 22.85 Mn |
| Sep 30, 2022 | 22.88 Mn |
| Jun 30, 2022 | 22.85 Mn |
| Mar 31, 2022 | 22.75 Mn |
| Dec 31, 2021 | 22.49 Mn |
| Sep 30, 2021 | 22.85 Mn |
| Jun 30, 2021 | 22.87 Mn |